VALENTINE KAREN (See Remarks) sold 17.20K shares of CONSTELLATION PHARMACEUTICALS INC on the open market
Open‑market sale worth $584.5K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 1/20/2021ACC: 0001562180-21-000392
Officer· See Remarks
Since Jul 2018
-17.20K
Net shares
Net seller
$584.5K
Total sold
3
Open market trades
0B · 3S
5
Total transactions
17.20K acquired · 34.41K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+17.20K
Price / share
$11.50
Trade value
$197.83K
% of position
New position
1/19/2021
0.00→17.20K
Common Stock
Direct
Shares
−8.77K
Price / share
$33.08
Trade value
$290.23K
% of position
51.0%
1/19/2021
17.20K→8.43K
Common Stock
Direct
Shares
−1.23K
Price / share
$33.69
Trade value
$41.34K
% of position
14.6%
1/19/2021
8.43K→7.20K
Common Stock
Direct
Shares
−7.20K
Price / share
$35.11
Trade value
$252.89K
% of position
New position
1/19/2021
7.20K→0.00
Total
Net shares
+0.00
Net value
-$386.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/19/2021 | M · Option Exercise | +17.20K | $11.50 | $197.83K | New position | 0.00 | 17.20K |
| Common Stock Direct | 1/19/2021 | S · Sale | −8.77K | $33.08 | $290.23K | 51.0% | 17.20K | 8.43K |
| Common Stock Direct | 1/19/2021 | S · Sale | −1.23K | $33.69 | $41.34K | 14.6% | 8.43K | 7.20K |
| Common Stock Direct | 1/19/2021 | S · Sale | −7.20K | $35.11 | $252.89K | New position | 7.20K | 0.00 |
| Total | +0.00 | -$386.63K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
17.20K shares
Shares
−17.20K
Strike price
11.50
Held after
81.94K
Exercisable
—
1/19/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock17.20K shares | 1/19/2021 | M · Option Exercise | −17.20K | 11.50 | — | 81.94K |